During the past decade, Allegheny Cancer Center at Allegheny General Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 36 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allegheny Cancer Center at Allegheny General Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 17 trials, followed by "NSABP Foundation Inc" with 12 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored and "SWOG Cancer Research Network" with 8 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allegheny Cancer Center at Allegheny General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Allegheny Cancer Center at Allegheny General Hospital" are "Breast Cancer" (15 trials), "Lung Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Brain and Central Nervous System Tumors" (3 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Allegheny Cancer Center at Allegheny General Hospital" in a lesser frequency.

Most popular intervention types in "Allegheny Cancer Center at Allegheny General Hospital" are "Drug" (57 trials), "Biological" (18 trials), "Radiation" (18 trials), "Procedure" (16 trials) and "Other" (14 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (10 trials), "fluorouracil" (8 trials), "Paclitaxel" (7 trials), "bevacizumab" (7 trials) and "cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Allegheny Cancer Center at Allegheny General Hospital" are 57 trials for "All" genders, 12 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Allegheny Cancer Center at Allegheny General Hospital". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Allegheny Cancer Center at Allegheny General Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Allegheny Cancer Center at Allegheny General Hospital, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".